Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2010612 | 1.00 | HSD11B1 (0.88) | HSD11B1IDH1 | |
| SCHEMBL12571166 | 1.00 | HSD11B1 (0.88) | HSD11B1IDH1 | |
| SCHEMBL2010609 | 1.00 | HSD11B1 (0.88) | HSD11B1IDH1 | |
| SCHEMBL1978821 | 0.95 | HSD11B1 (0.80) | HSD11B1IDH1 | |
| SCHEMBL4457993 | 0.95 | HSD11B1 (0.80) | HSD11B1IDH1 | |
| SCHEMBL1972608 | 0.95 | HSD11B1 (0.80) | HSD11B1IDH1 | |
| SCHEMBL4461153 | 0.95 | HSD11B1 (0.80) | HSD11B1IDH1 | |
| SCHEMBL12571155 | 0.95 | HSD11B1 (0.80) | HSD11B1IDH1 | |
| SCHEMBL1972545 | 0.95 | HSD11B1 (0.80) | HSD11B1IDH1 | |
| SCHEMBL1972548 | 0.95 | HSD11B1 (0.80) | HSD11B1IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7964618-B2 | 2-[(3R)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanyl-pyridin-2-yl]-3-piperidyl]acetic acid, for example; compounds possess human 11- beta-hydroxysteroid dehydrogenase type1 enzyme (11 beta HSD1) inhibitory activity and accordingly have value in treatment of disease states including metabolic syndrome | ASTRAZENECA AB (SE) | 2011-06-21 | — | — | US | disclosed |
| EP-2233480-A1 | Chemical compounds | AstraZeneca AB (SE) | 2010-09-29 | — | — | EP | disclosed |